Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area jak stat signaling stat'

Search results for: 'research area jak stat signaling stat'

Items 1-10 of 53

Page
per page
  1. Cucurbitacin I
    A4512 Cucurbitacin I
    Target: STAT|JAK
    Summary: STAT3/JAK2 signaling inhibitor
      ≥22.45 mg/mL
  2. Fludarabine
    A5424 Fludarabine
    Summary: DNA synthsis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL
  3. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  4. Ruxolitinib (INCB018424)
    A3012 Ruxolitinib (INCB018424)
     4 Citation
    Target: JAK
    Summary: JAK inhibitor
      insoluble in H2O; ≥15.32 mg/mL
  5. TG101348 (SAR302503)
    A4136 TG101348 (SAR302503)
     2 Citation
    Target: FLT3|JAK|c-RET
    Summary: JAK-2 inhibitor,potent and selective
      ≥26.23 mg/mL
  6. XL019
    A3937 XL019
    Target: JAK
    Summary: JAK2 inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥11.125 mg/mL
  7. AG-490
    A4139 AG-490
     3 Citation
    Target: EGFR|JAK
    Summary: JAK2/EGFR inhibitor
      insoluble in H2O; ≥14.7 mg/mL
  8. Wnt-C59
    A8685 Wnt-C59
     2 Citation
    Target: PORCN
    Summary: PORCN inhibitor,highly potent and selective
      .95 mg/mL
      insoluble in H2O; ≥18
  9. SB 203580
    A8254 SB 203580
     9 Citation
    Target: p38|PKB
    Summary: P38 MAP kinase inhibitor
      insoluble in H2O; ≥18.872 mg/mL
  10. Niclosamide
    B2283 Niclosamide
    Target: STAT
    Summary: Inhibitor of the STAT3 signaling pathway

Items 1-10 of 53

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
  3. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 2item
  2. Chromatin/Epigenetics 6item
  3. Metabolism 2item
  4. MAPK Signaling 11item
  5. Tyrosine Kinase 4item
  6. DNA Damage/DNA Repair 1 item
  7. PI3K/Akt/mTOR Signaling 17item
  8. JAK/STAT Signaling 9item
  9. TGF-β / Smad Signaling 5item
  10. Stem Cell 5item
  11. Membrane Transporter/Ion Channel 1 item
  12. Endocrinology and Hormones 1 item
  13. Neuroscience 2item
  14. Obesity, Appetite Control & Diabetes 1 item
  15. Other Signal Transduction 1 item
  16. Immunology/Inflammation 1 item
  17. Cardiovascular 1 item
Target
  1. Akt 2item
  2. PI3K 8item
  3. Raf 4item
  4. mTOR 4item
  5. Androgen Receptors 1 item
  6. FLT3 1 item
  7. GSK-3 3item
  8. VEGFR 2item
  9. PDGFR 1 item
  10. Phosphodiesterases (PDEs) 1 item
  11. p38 4item
  12. PKB 1 item
  13. MEK 3item
  14. PORCN 1 item
  15. FGFR 1 item
  16. GABAB Receptors 1 item
  17. STAT 2item
  18. EGFR 2item
  19. JAK 7item
  20. Syk 1 item
  21. HSP90 1 item
  22. Toll-like receptors (TLRs) 1 item
  23. ERK 1 item
  24. PKC 3item
  25. NO Donors / Precursors 1 item
  26. IL Receptors 1 item
  27. c-RET 1 item
  28. TYK2 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 3item
  3. Bladder Cancer 1 item
  4. Breast Cancer 14item
  5. Cancer 34item
  6. Cervical Cancer 1 item
  7. Colon Cancer 6item
  8. Colorectal Cancer 6item
  9. Glioblastoma 8item
  10. Glioma 3item
  11. HIV Infections 1 item
  12. Leukemia 7item
  13. Liver Cancer 1 item
  14. Lung Cancer 4item
  15. Lymphoma 3item
  16. Melanoma 4item
  17. Multiple Myeloma 1 item
  18. Myelofibrosis 1 item
  19. Myeloma 1 item
  20. Neuroblastoma 1 item
  21. Non-small Cell Lung Cancer 4item
  22. Ovarian Cancer 5item
  23. Pancreatic Cancer 6item
  24. Pancreatic Carcinoma 1 item
  25. Prostate Cancer 8item
  26. Psoriasis 1 item
  27. Pulmonary Fibrosis 1 item
  28. Rheumatoid Arthritis 3item
  29. Thyroid Cancer 2item
  30. Type 2 Diabetes 1 item